specialities.png       

FRANÇAIS / ENGLISH       

 
 
spacing10px.png
R&D

Research at Omega includes the development of generic pharmaceuticals. Since its inception, Omega’s scientific expertise has grown tremendously. We continuously reinvest towards R&D, and we are committed to investing even more in the future.

Omega Laboratories Limited invests approximately $3 million annually in research and development of a wide range of therapeutic products in various areas, including cardiovascular diseases, infectious diseases, neurological diseases, and oncology.


spacing10px.png
spacing10px.png